ReviewChemical reviews2010
Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.
Abstract readReview
In one paragraph
Review in Chemical reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Characterization of peripheral nerve sheath tumors with 3T proton MR spectroscopy.AJNR. American journal of neuroradiology · 2014Trial
- Monitoring Pharmacological Treatment of Breast Cancer with MRI.Current issues in molecular biology · 2025Review
- Multifunctional Poly(Acrylic Acid)-Coated EuBiGdInternational journal of nanomedicine · 2025Article
- An Update on MR Spectroscopy in Cancer Management: Advances in Instrumentation, Acquisition, and Analysis.Radiology. Imaging cancer · 2024Review
- Biomarkers in Cancer Detection, Diagnosis, and Prognosis.Sensors (Basel, Switzerland) · 2023Review
- Supramolecular and biomacromolecular enhancement of metal-free magnetic resonance imaging contrast agents.Chemical science · 2020Article
- A Ln(III)-3-hydroxypyridine pH responsive probe optimized by DFT.RSC advances · 2020Article
- In Situ Ligation of High- and Low-Affinity Ligands to Cell Surface Receptors Enables Highly Selective Recognition.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2017Article
- Nitroxide-Based Macromolecular Contrast Agents with Unprecedented Transverse Relaxivity and Stability for Magnetic Resonance Imaging of Tumors.ACS central science · 2017Article
- Visualization of Fluoride Ions In Vivo Using a Gadolinium(III)-Coumarin Complex-Based Fluorescence/MRI Dual-Modal Probe.Sensors (Basel, Switzerland) · 2016Article
- Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.Progress in lipid research · 2016Review
- In vivo MR spectroscopy of human breast tissue: quantification of fatty acid composition at a clinical field strength (3 T).Magma (New York, N.Y.) · 2016Article
- Supramolecularly engineered phospholipids constructed by nucleobase molecular recognition: upgraded generation of phospholipids for drug delivery.Chemical science · 2015Article
- Widefield optical imaging of changes in uptake of glucose and tissue extracellular pH in head and neck cancer.Cancer prevention research (Philadelphia, Pa.) · 2014Article
- Quantification in magnetic resonance spectroscopy based on semi-parametric approaches.Magma (New York, N.Y.) · 2014Review
- A dual sensor for real-time monitoring of glucose and oxygen.Biomaterials · 2013Article
- Environmentally responsive MRI contrast agents.Chemical communications (Cambridge, England) · 2013Review
- Combined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model.NMR in biomedicine · 2013Article
- Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer.Breast cancer research : BCR · 2013Article
- Lactate detection in inducible and orthotopic Her2/neu mammary gland tumours in mouse models.NMR in biomedicine · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Kristine GlundeJHU ICMIC Program, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. kglunde@mri.jhu.edu
Dmitri Artemov
Marie-France Penet
Michael A Jacobs
Zaver M Bhujwalla
Funding
Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6MVACCINES--A NEW PARADIGM FOR BREAST CANCERP50CA088843 · NCI · JOHNS HOPKINS UNIVERSITY · PI DAVIDSON, NANCY ELLEN · 2000 to 2010
$27.8MTheranostic Imaging of Metastatic Prostate CancerP50CA103175 · NCI · JOHNS HOPKINS UNIVERSITY · PI BARKER, PETER B · 2003 to 2015
$17.9MPHASE I TRIALS OF ANTICANCER AGENTSU01CA070095 · NCI · JOHNS HOPKINS UNIVERSITY · PI CARDUCCI, MICHAEL A · 1995 to 2013
$8.6MMulti-Modality Quantitiative Imaging for Evaluation of Response to Cancer TherapyU01CA140204 · NCI · JOHNS HOPKINS UNIVERSITY · PI DU, YONG, SOLNES, LILJA · 2011 to 2022
$6.1MHOSTILE ENVIRONMENTS PROMOTE INVASION AND METATASISR01CA082337 · NCI · JOHNS HOPKINS UNIVERSITY · PI BHUJWALLA, ZAVER M. · 1999 to 2024
$5.1MFUNTIONAL IMAGING OF THE METASTATIC PHENOTYPER01CA073850 · NCI · JOHNS HOPKINS UNIVERSITY · PI BHUJWALLA, ZAVER M. · 1997 to 2014
$3.5MImaging Hypoxia and Cancer Stem CellsR01CA136576 · NCI · JOHNS HOPKINS UNIVERSITY · PI BHUJWALLA, ZAVER M. · 2009 to 2017
$2.4MImage-guided Prodrug and siRNA Targeting of CancerR01CA138515 · NCI · JOHNS HOPKINS UNIVERSITY · PI BHUJWALLA, ZAVER M. · 2009 to 2013
$1.7MImaging hypoxia-driven signaling pathways in the breast tumor microenvironmentR01CA134695 · NCI · JOHNS HOPKINS UNIVERSITY · PI GLUNDE, KRISTINE · 2008 to 2012
$1.5MMultiparametric MRI characterization of breast tissueR01CA100184 · NCI · JOHNS HOPKINS UNIVERSITY · PI JACOBS, MICHAEL · 2004 to 2009
$1.4MActivated nano-sized MR contrast agents for imaging of tumor proteolytic activityR21CA133288 · NCI · JOHNS HOPKINS UNIVERSITY · PI ARTEMOV, DMITRI · 2009 to 2010
$397kNCI NIH HHS P30 CA006973NCI NIH HHS P50 CA088843NCI NIH HHS P50 CA103175NCI NIH HHS P50 CA88843NCI NIH HHS R01 CA073850NCI NIH HHS R01 CA082337NCI NIH HHS R01 CA100184NCI NIH HHS R01 CA134695NCI NIH HHS R01 CA136576NCI NIH HHS R01 CA138515NCI NIH HHS R01 CA73850NCI NIH HHS R01 CA82337NCI NIH HHS R21 CA133288NCI NIH HHS U01 CA070095NCI NIH HHS U01 CA140204
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsHumansMagnetic Resonance SpectroscopyMolecular ImagingNeoplasmsTreatment Outcome
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.